Stroke Clinical Trials in New Haven, Connecticut

6 studies are recruiting for stroke in New Haven, Connecticut right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Treatment With Endovascular Intervention for STroke Patients With Existing Disability

   TESTED will compare the risks and benefits of endovascular thrombectomy (EVT) to medical management (no EVT) in ischemic stroke patients who have a blockage in one of the large blood vessels in the brain and have a moderate-to-severe disability prior to their stroke.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Yale University, New Haven, Connecticut

   Locations

   35 in total

   Run by

   University of Cincinnati

   See if you can join NCT05911568 on ClinicalTrials.gov

2. Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials

   VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore these biomarkers in acute intracerebral hemorrhage. VERIFY will create the first multicenter, large-scale, prospective dataset of clinical, tra…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Yale New Haven Hospital, New Haven, Connecticut

   Locations

   45 in total

   Run by

   Yale University

   See if you can join NCT05338697 on ClinicalTrials.gov

3. GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study

   This study will assess the safety and effectiveness of GORE® CARDIOFORM Septal Occluder in a post approval setting and evaluate the quality of operator education and training and transferability of trial experience to a post-market setting.

   Stage

   Not phased

   Ages

   18 to 70

   Site

   Yale University School of Medicine, New Haven, Connecticut

   Locations

   45 in total

   Run by

   W.L.Gore & Associates

   See if you can join NCT03821129 on ClinicalTrials.gov

4. Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging

   CAPTIVA-MRI is an observational multimodal MR imaging study that is ancillary to the CAPTIVA trial [a 3-arm, double-blind Phase III trial conducted at approximately 115 StrokeNet sites randomizing patients with stroke attributed to 70-99% intracranial atherosclerotic stenosis (ICAS) to aspirin plus…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Yale New Haven Hospital, New Haven, Connecticut

   Locations

   28 in total

   Run by

   Yale University

   See if you can join NCT05907629 on ClinicalTrials.gov

5. Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

   The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated c…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Yale Medicine, New Haven, Connecticut

   Locations

   106 in total

   Run by

   Icahn School of Medicine at Mount Sinai

   See if you can join NCT04045665 on ClinicalTrials.gov

6. Stroke Thrombectomy and Aneurysm Registry

   This international multi-center registry is used to collect existing information and outcomes for patients undergoing an operation for treatment of injuries to the brain including the blockage of blood flow to an area of the brain, an abnormal ballooning of an artery, abnormal tangling of blood ves…

   Stage

   Not phased

   Ages

   1 to 120

   Site

   Yale University, New Haven, Connecticut

   Locations

   63 in total

   Run by

   Medical University of South Carolina

   See if you can join NCT04994756 on ClinicalTrials.gov